These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20943623)

  • 1. Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.
    Posner MR
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii246-51. PubMed ID: 20943623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Krstevska V
    J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemotherapy and radiotherapy for head and neck cancer.
    Burri RJ; Lee NY
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in head and neck cancer.
    Agarwala SS
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):743-52, vii. PubMed ID: 10494510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure.
    Scher RL; Esclamado RM
    Semin Radiat Oncol; 2009 Jan; 19(1):17-23. PubMed ID: 19028341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer.
    Wolff HA; Daldrup B; Jung K; Overbeck T; Hennies S; Matthias C; Hess CF; Roedel RM; Christiansen H
    Radiology; 2011 Mar; 258(3):864-71. PubMed ID: 21339350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
    Brizel DM; Esclamado R
    J Clin Oncol; 2006 Jun; 24(17):2612-7. PubMed ID: 16763273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer.
    Norris CM; Busse PM; Clark JR
    Semin Surg Oncol; 1993; 9(1):3-13. PubMed ID: 8356382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
    Herchenhorn D; Ferreira CG
    J Clin Oncol; 2011 Apr; 29(10):e283-4; author reply e285-7. PubMed ID: 21300921
    [No Abstract]   [Full Text] [Related]  

  • 17. Current treatments and promising investigations in a multidisciplinary setting.
    Vokes E
    Ann Oncol; 2005; 16 Suppl 6():vi25-vi30. PubMed ID: 15987993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
    Bernier J; Bentzen SM
    Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.